Tower Trust & Investment Company’s Edwards Lifesciences EW Stock Holding History

Tower Trust & Investment Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.27K	Buy	+14	New	+$1.17K	﹤0.01%	217

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Tower Trust & Investment Company's EW Position: Q2 2026 in Review

Tower Trust & Investment Company opened a new position in Edwards Lifesciences (EW) in Q2 2026: 14 shares worth $1.27K. The stake represents ﹤0.01% of the portfolio and ranks #217 among its holdings.

563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Tower Trust & Investment Company held 14 shares of Edwards Lifesciences worth $1.27K as of Q2 2026.
Edwards Lifesciences was a new Tower Trust & Investment Company position in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of Tower Trust & Investment Company's portfolio in Q2 2026, its #217 holding.
563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.